GlobeStar Therapeutics Corp Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
GlobeStar Therapeutics Corp quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • GlobeStar Therapeutics Corp Return On Equity for the quarter ending June 30, 2024 was 58.6 %, a 61.6% decline year-over-year.
  • GlobeStar Therapeutics Corp annual Return On Equity for 2023 was 149 %, a 3.57% increase from 2022.
  • GlobeStar Therapeutics Corp annual Return On Equity for 2022 was 144 %, a 91.1% decline from 2021.
  • GlobeStar Therapeutics Corp annual Return On Equity for 2021 was 1.61K %, a 1765% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 58.6 -94 -61.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 138 +71.3 +107% Jan 1, 2024 Mar 31, 2024
Q4 2023 141 +22.9 +19.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 149 +5.13 +3.57% Jul 1, 2023 Sep 30, 2023
Q2 2023 153 -440 -74.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 66.8 -1.11K -94.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 118 -1.4K -92.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 144 -1.47K -91.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 593 -375 -38.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 1.18K +958 +439% Jan 1, 2022 Mar 31, 2022
Q4 2021 1.52K +1.44K +1835% Oct 1, 2021 Dec 31, 2021
Q3 2021 1.61K +1.53K +1765% Jul 1, 2021 Sep 30, 2021
Q2 2021 968 +885 +1069% Apr 1, 2021 Jun 30, 2021
Q1 2021 218 +152 +229% Jan 1, 2021 Mar 31, 2021
Q4 2020 78.5 +7.77 +11% Oct 1, 2020 Dec 31, 2020
Q3 2020 86.6 -0.49 -0.56% Jul 1, 2020 Sep 30, 2020
Q2 2020 82.8 -7.19 -7.99% Apr 1, 2020 Jun 30, 2020
Q1 2020 66.2 -33.6 -33.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 70.7 -12.4 -14.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 87.1 -15.7 -15.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 90 -126 -58.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 99.7 -106 -51.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 83.1 -130 -60.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 103 -85.8 -45.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 216 Apr 1, 2018 Jun 30, 2018
Q1 2018 206 Jan 1, 2018 Mar 31, 2018
Q4 2017 213 Oct 1, 2017 Dec 31, 2017
Q3 2017 189 Jul 1, 2017 Sep 30, 2017
Q2 2016 -141 -803 -121% Apr 30, 2016 Jun 30, 2016
Q1 2016 761 -304 -28.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 976 +25.2 +2.65% Oct 1, 2015 Dec 31, 2015
Q3 2015 880 -422 -32.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 663 -17.2K -96.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 1.06K +4.71K Jan 1, 2015 Mar 31, 2015
Q4 2014 951 +2.52K Oct 1, 2014 Dec 31, 2014
Q3 2014 1.3K +3.39K Jul 1, 2014 Sep 30, 2014
Q2 2014 17.9K +16.2K +949% Apr 1, 2014 Jun 30, 2014
Q1 2014 -3.64K -4.62K -470% Jan 1, 2014 Mar 31, 2014
Q4 2013 -1.57K -2.19K -350% Oct 1, 2013 Dec 31, 2013
Q3 2013 -2.09K -2.79K -399% Jul 1, 2013 Sep 30, 2013
Q2 2013 1.7K +1.01K +147% Apr 1, 2013 Jun 30, 2013
Q1 2013 983 +624 +174% Jan 1, 2013 Mar 31, 2013
Q4 2012 626 Oct 1, 2012 Dec 31, 2012
Q3 2012 699 Jul 1, 2012 Sep 30, 2012
Q2 2012 689 Apr 1, 2012 Jun 30, 2012
Q1 2012 359 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.